Revenue Analysis - COLL
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
COLL Corporation
Annual
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Belbuca
0.0% of total revenue
$52.6M
Xtampza ER
0.0% of total revenue
$50.8M
Nucynta IR
0.0% of total revenue
$26.1M
Nucynta ER
0.0% of total revenue
$18.2M
Symproic
0.0% of total revenue
$4.2M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Belbuca | Nucynta ER | Nucynta IR | Symproic | Xtampza ER |
|---|---|---|---|---|---|
| 3/31/2026 | $52.6M | $18.2M | $26.1M | $4.2M | $50.8M |
| 12/31/2025 | $59.1M | $18.5M | $29.4M | $0 | $48.6M |
| 9/30/2025 | $58.3M | $22.8M | $32.0M | $4.0M | $50.5M |
| 6/30/2025 | $52.6M | $19.9M | $26.5M | $3.7M | $52.6M |
| 3/31/2025 | $51.7M | $19.7M | $27.4M | $2.8M | $47.6M |
| 12/31/2024 | $107.4M | $36.8M | $49.4M | $8.3M | $96.0M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Declining Segments
Nucynta IR-11.3%
Belbuca-11.0%
Earnings Reports
Want to see how COLL's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports